HFCIX
MDLN

H&F Corporate Investors X’s Medline Inc MDLN Stock Holding History

H&F Corporate Investors X’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.85B Sell
86,473,497
-13,040,572
-13% -$576M 100% 1
2025
Q4 		$4.18B Buy
+99,514,069
New +$4.2B 100% 1

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

H&F Corporate Investors X's MDLN Position: Q1 2026 in Review

H&F Corporate Investors X reduced its Medline Inc (MDLN) stake by 13% in Q1 2026, selling an estimated $576M and leaving 86,473,497 shares worth $3.85B. The position accounts for 100% of the portfolio, ranked #1.

H&F Corporate Investors X first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. The position peaked at $4.18B in Q4 2025. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • H&F Corporate Investors X held 86,473,497 shares of Medline Inc worth $3.85B as of Q1 2026.
  • H&F Corporate Investors X sold 13,040,572 Medline Inc shares in Q1 2026, an estimated $576M.
  • Medline Inc made up 100% of H&F Corporate Investors X's portfolio in Q1 2026, its #1 holding.
  • H&F Corporate Investors X first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
  • H&F Corporate Investors X's Medline Inc position peaked at $4.18B in Q4 2025.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on H&F Corporate Investors X's 13F filing for Q1 2026, filed 11 May 2026.